Public Trust in Experts: It’s on Us to Be the Solution | Andrew Coop, PhD, MA | School of Pharmacy
How do researchers and scholars build public trust? It's all about integrity and benevolence.Andrew Coop, PhD, MA, professor in the Department of Pharmaceutical Sciences and associate dean for Graduate Programs in the University of Maryland School of Pharmacy, shared those words during the third annual Faculty Convocation at the University of Maryland, Baltimore.Dr. Coop has been a faculty member at the University of Maryland School of Pharmacy since 1999, serving as chair of the Department of Pharmaceutical Sciences (PSC) from 2007 to 2015. In addition to his current role as UMSOP’s associate dean for graduate programs, he previously served as the school’s associate dean for academic affairs from 2016 to 2024 and as PSC’s vice chair of academic affairs from 2006 to 2007. Coop has received funding from the National Institutes of Health’s National Institute on Drug Abuse for his research on opioids, stimulants, and depressants, all of which were interdisciplinary projects concerned with the design and development of novel tools to allow pharmacological study of the biological systems involved in the abuse of these drugs
More from Youtube
- 0:40Balancing Inflammation: Hope for Reducing ARDS ComplicationsWhat if we could help the body manage inflammation before it becomes dangerous? At the University of Maryland, Baltimore, researchers Paul Shapiro, PhD, and Jeffrey Hasday, MD, are studying protein kinases — enzymes that regulate immune signaling. Their work could lead to breakthroughs in reducing acute respiratory distress syndrome (ARDS) and related health issues.#BreakthroughsCantWaitUMB #ARDS #MedicalResearch #Inflammation #PharmaceuticalScience #ImmuneBalance #BreakthroughsCantWaitUMB
- 0:57Anti-Inflammatory Drug Offers Hope | Breakthroughs Can't WaitWhat if we could reset the balance between inflammation and anti-inflammation in the body?That’s exactly what researchers Paul Shapiro, PhD (University of Maryland School of Pharmacy), and Jeffrey Hasday, MD (University of Maryland School of Medicine), are working toward.By exploring protein kinases—enzymes involved in regulating inflammation—they’re investigating ways to support long-term health and conditions related to immune overreaction, such as respiratory and muscular disorders.#BreakthroughsCantWaitUMB #InflammationResearch #ChronicPain #NIH